HEALTH (ALT)

Circumcision – Accepted genital mutilation

(NaturalNews) It’s a funny thing. Every culture has its way of doing things. You grow up in a culture, and you accept many things without ever questioning them. And yet, it’s hard to believe that so many Americans in the last 150 years have accepted genital mutilation without question…

KWN HEALTH

HEALTH (MSM)

US regulators discuss 'female Viagra'

Advisors to US regulators looked for a third time Thursday at the merits of a drug nicknamed the “female Viagra” because it could help increase women’s sex drive. If the US Food and Drug Administration gives flibanserin the go-ahead, it would be the first drug on the market designed to boost female libido. Flibanserin, which is aimed at pre-menopausal women, also can have significant side effects including nausea, dizziness and

Diabetes pill may lower risk of eye disease in elderly

By Lisa Rapaport (Reuters Health) – Metformin, a pill that lowers blood sugar in people with diabetes, might also reduce their risk of developing glaucoma, an eye disease that can lead to vision loss and blindness, a new study suggests. While the results can’t prove the drug prevents glaucoma, researchers found that diabetics taking higher doses of metformin were less likely to develop the eye disease than those who used

EU drug agency sees no U.S.-like cannabis legalization moves

By Andrei Khalip LISBON (Reuters) – European Union countries are unlikely to legalize marijuana any time soon as some parts of the United States have done recently, EU drug monitoring agency chief Wolfgang Gotz said on Thursday. It also pointed out an increase in the numbers of cannabis-related health emergencies in Europe between 2008 and 2012. Gotz told a briefing arranged to present the European Monitoring Centre for Drugs and

Carmat to give fourth patient artificial heart within three months

Carmat will equip a fourth patient with an artificial heart within three months at most, one of the company’s founders told BFM television on Wednesday. The French company is conducting trials of its heart device that is designed as a permanent implant to extend the life of patients without them having to wait for a human heart donor. Carmat’s first transplant patient, a 76-year-old man, died in March last year,